MedPath

A prospective observational study to evaluate the prescribing pattern and microbial sensitivity of antimicrobial agents in Gram-negative severe sepsis/septic shock patients in medical intensive care unit at tertiary care hospital.

Recruiting
Conditions
Severe Sepsis/ Septic Shock
Registration Number
CTRI/2014/03/004441
Lead Sponsor
Not Applicable
Brief Summary

| | |

| --- | --- |

| Protocol Title

  A prospective observational study to evaluate the prescribing pattern and microbial sensitivity of antimicrobial agents in Gram-negative severe sepsis/septic shock patients in medical intensive care unit at tertiary care hospital.

| Protocol No:

 PPMS-01

| Version number

 1.0, Dated-5/09/13

| Primary objective

    Secondary objective

   To evaluate the prescribing pattern and microbial sensitivity of antimicrobial agents in Gram- negative severe sepsis/ septic shock patients in MICU at tertiary care hospital.

 1. To determine the epidemiology of Gram- negative severe sepsis/septic shock in MICU at tertiary care hospital.

2. To determine the clinical outcomes of Gram- negative severe sepsis/septic shock patients admitted in the MICU.

  

| Study design

  Prospective Observational study

| Study Duration

 6 months

| Methodology

 In this study, data of the patients, who suffered from Gram-negative severe sepsis/septic shock, will be collected prospectively, from MICU, Max Super Specialty Hospital, Patpargunj, New Delhi, and the prescribing pattern and microbial sensitivity will be studied and evaluated

| Study Population

  Both males and females

| Data Collection

 All the variables will be noted in the data collection sheet.

| Ethics and Responsibility

  The protocol will be submitted to IEC of Max Super Specialty Hospital.

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
85
Inclusion Criteria
  • •Patients with severe sepsis/septic shock admitted to the medical intensive care unit.
  • •Patients aged above 18 years and below 65 years •Patients who are receiving antimicrobial agents.
Exclusion Criteria

•Patients with less than 8 hours of length of stay in the ICU.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the major antibiotic prescribed in Gram- negative severe sepsis/ septic shock patients admitted in MICU.After recruitment we analyze our outcome.
2. To determine the Gram- negative micro-organism isolated in the positive culture and their sensitivity against the antimicrobial agents.After recruitment we analyze our outcome.
Secondary Outcome Measures
NameTimeMethod
Not ApplicableNot Applicable

Trial Locations

Locations (1)

Max Super Speciality Hospital

🇮🇳

Delhi, DELHI, India

Max Super Speciality Hospital
🇮🇳Delhi, DELHI, India
DrYP Singh
Principal investigator
08800531155
yogendra.singh2@maxhealthcare.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.